IL6 and neoplasm: IL-6 rises great attention in oncology, since trans-signaling due to soluble form of the IL-6 receptor not only accounts for more recurrent inflammation, but also enhances chemotherapy-resistance, tumor growth, metastasization and epithelial to mesenchymal transition [74–76].